# Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury

> **NCT03389685** · PHASE2 · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- ACL - Anterior Cruciate Ligament Rupture
- ACL Injury

## Interventions

- **BIOLOGICAL:** Platelet Rich Plasma
- **OTHER:** Saline Placebo

## Key facts

- **NCT ID:** NCT03389685
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-09-09
- **Primary completion:** 2024-02
- **Final completion:** 2024-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** COVID-19, Lack of Funding
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03389685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03389685, "Can PRP Reduce Pro-Inflammatory Biomarkers Following ACL Injury". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03389685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*